| 英文名称 |
中文名称 |
CAS号 |
操作 |
| PNU112455A hydrochloride |
N4-(6-AMINOPYRIMIDIN-4-YL)-SULFANILAMIDE HCL |
21886-12-4 |
详细
|
| CDK12-IN-2 |
化合物CDK12-IN-2 |
2244987-03-7 |
详细
|
| MBQ-167 |
MBQ 167;MBQ167 |
2097938-73-1 |
详细
|
| CDK4/6-IN-2 |
|
1800506-48-2 |
详细
|
| CDK12-IN-E9 |
CDK12 inhibitor E9 S-isomer |
2020052-55-3 |
详细
|
| BRD6989 |
|
642008-81-9 |
详细
|
| THZ2 |
|
1604810-84-5 |
详细
|
| PSB-12379 |
|
1802226-78-3 |
详细
|
| CD73-IN-3 |
5-[6-甲基-5-[(1S,2R)-2-丙-2-基环丙基]哒嗪-3-基]-1H-嘧啶-2,4-二酮 |
2375815-63-5 |
详细
|
| Fadraciclib |
CYC-065 |
1070790-89-4 |
详细
|
| Trilaciclib |
曲拉西利 |
1374743-00-6 |
详细
|
| Cdc7-IN-1 |
CDC7-IN-1 (COMPOUND 13) |
1402055-25-7 |
详细
|
| MSC2530818 |
|
1883423-59-3 |
详细
|
| CDK9-IN-8 |
|
2105956-51-0 |
详细
|
| (-)-Enitociclib |
(-)-BAY-1251152 |
1610358-59-2 |
详细
|
| CLK1-IN-1 |
2123491-32-5 |
2123491-32-5 |
详细
|
| CDK8-IN-1 |
|
1629633-48-2 |
详细
|
| THZ531 |
|
1702809-17-3 |
详细
|
| CK7 |
CDK2/9 INHIBITOR |
507487-89-0 |
详细
|
| Bisindolylmaleimide X hydrochloride |
BISINDOLYLMALEIMIDE X HYDROCHLORIDE (BIM-X HYDROCHLORIDE) |
145317-11-9 |
详细
|
| PHA-793887 |
3-甲基-N-[1,4,5,6-四氢-6,6-二甲基-5-[(1-甲基-4-哌啶基)甲酰基]吡咯并[3,4-C]吡唑-3-基]丁酰胺 |
718630-59-2 |
详细
|
| CDK8-IN-4 |
|
1613638-82-6 |
详细
|
| CDK12-IN-3 |
|
2220184-50-7 |
详细
|
| Lerociclib dihydrochloride |
LEROCICLIB HCL ; G1T38 DIHYDROCHLORIDE ; G1T 38 DIHYDROCHLORIDE |
2097938-59-3 |
详细
|
| AB-680 |
|
2105904-82-1 |
详细
|
| OP-5244 |
|
2381268-71-7 |
详细
|
| Enitociclib |
1610358-56-9 |
1610358-56-9 |
详细
|
| Milciclib |
PHA-848125 |
802539-81-7 |
详细
|
| CC-671 |
|
1618658-88-0 |
详细
|
| NVP-2 |
化合物NVP-2 |
1263373-43-8 |
详细
|
| SRI-29329 |
化合物SRI-29329 |
2086809-58-5 |
详细
|
| LY3177833 |
CS-2783 |
1627696-51-8 |
详细
|
| DRAK2-IN-1 |
|
871837-60-4 |
详细
|
| CD73-IN-4 |
化合物CD73-IN-4 |
2216764-29-1 |
详细
|
| AZD4573 |
|
2057509-72-3 |
详细
|
| THAL-SNS-032 |
|
2139287-33-3 |
详细
|
| Voruciclib |
|
1000023-04-0 |
详细
|
| Mevociclib |
SY-1365 |
1816989-16-8 |
详细
|
| Atuveciclib S-Enantiomer |
|
250279-81-1 |
详细
|
| PROTAC CDK2/9 Degrader-1 |
|
2408641-24-5 |
详细
|
| CPS2 |
化合物 CPS2 |
2756741-90-7 |
详细
|
| dCeMM2 |
化合物 DCEMM2 |
296771-07-8 |
详细
|
| TNIK-IN-3 |
化合物TNIK-IN-3 |
2754265-25-1 |
详细
|
| Eciruciclib |
化合物 ECIRUCICLIB |
1868086-40-1 |
详细
|
| AUZ 454 |
K03861 |
853299-07-7 |
详细
|
| BMS-265246 |
BMS265246 |
582315-72-8 |
详细
|
| Ribociclib hydrochloride |
7-环戊基-N,N-二甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]-7H-吡咯并[2,3-D]嘧啶-6-甲酰胺盐酸盐 |
1211443-80-9 |
详细
|
| AZ5576 |
化合物AZ5576 |
2751721-40-9 |
详细
|
| CDK9-IN-7 |
|
2369981-71-3 |
详细
|
| CKI-7 free base |
CKI-7 |
120615-25-0 |
详细
|
| CDK4/6-IN-6 |
|
2380321-51-5 |
详细
|
| WEE1-IN-5 |
化合物DEBIO-0123 |
2243882-74-6 |
详细
|
| NG 52 |
2-[[6-[(3-氯苯基)氨基]-9-异丙基-9H-嘌呤-2-基]氨基]乙醇 |
212779-48-1 |
详细
|
| CVT-313 |
CVT 313 |
199986-75-9 |
详细
|
| Ipivivint |
|
1481617-15-5 |
详细
|
| SY-5609 |
7-(二甲基膦基)-3-[2-[[(3S)-6,6-二甲基-3-哌啶基]氨基]-5-(三氟甲基)-4-嘧啶基]-1H-吲哚-6-甲腈 |
2417302-07-7 |
详细
|
| Ribociclib succinate |
LEE011 琥珀酸盐 |
1374639-75-4 |
详细
|
| HS38 |
2-[[1-(3-Chlorophenyl)-4-oxo-5H-pyrazolo[5,4-d]pyrimidin-6-yl]sulfanyl]propanamide |
1030203-81-6 |
详细
|
| Palbociclib-d8 |
帕博西尼-D8 |
1628752-83-9 |
详细
|
| AT7519 |
4-[(2,6-二氯苄基)氨基]-N-4-哌啶1H-吡唑-3-羧胺 |
844442-38-2 |
详细
|
| AT7519 Hydrochloride |
N-(4-哌啶基)-4-(2,6-二氯苄氨基)-1H-吡唑-3-羧胺盐酸盐 |
902135-91-5 |
详细
|
| NCT02 |
2-{5H,6H,7H-茚并[5,6-B]呋喃-3-基}-N-(5-甲基-1,3-噻唑-2-基)乙酰胺 |
790245-61-3 |
详细
|
| Aminopurvalanol A |
|
220792-57-4 |
详细
|
| CDKI-73 |
CS-2259 |
1421693-22-2 |
详细
|
| NSC 107512 |
化合物 NSC 107512 |
22242-89-3 |
详细
|
| Abemaciclib |
阿贝西利 |
1231929-97-7 |
详细
|
| CDK9-IN-2 |
N2'-(反式-4-氨基环己基)-5'-氯-N6-[(3-氟苯基)甲基]-[2,4'-联吡啶]-2',6-二胺 |
1263369-28-3 |
详细
|
| Riviciclib hydrochloride |
P276-00 |
920113-03-7 |
详细
|
| CDK7/12-IN-1 |
化合物 CDK7/12-IN-1 |
2654075-94-0 |
详细
|
| SR-4835 |
|
2387704-62-1 |
详细
|
| CFTR corrector 4 |
|
1918142-34-3 |
详细
|
| DB1113 |
INDEX NAME NOT YET ASSIGNED |
2769753-53-7 |
详细
|
| KH-CB20 |
|
1354448-60-4 |
详细
|
| Longdaysin |
9H-Purin-6-aMine, 9-(1-Methylethyl)-N-[[3-(trifluoroMethyl)phenyl]Methyl]- |
1353867-91-0 |
详细
|
| FN-1501 |
1429515-59-2 |
1429515-59-2 |
详细
|
| (E/Z)-Zotiraciclib hydrochloride |
化合物 (E/Z)-ZOTIRACICLIB HYDROCHLORIDE |
1321626-25-8 |
详细
|
| Navocaftor |
|
2159103-66-7 |
详细
|
| BPR1R024 |
|
2503015-75-4 |
详细
|
| c-Fms-IN-13 |
化合物C-FMS-IN-13 |
885704-58-5 |
详细
|
| AZD7507 |
CS-2850 |
1041852-85-0 |
详细
|
| NGR peptide |
细胞穿膜肽 NGR PEPTIDE |
651328-78-8 |
详细
|
| Torcetrapib |
托彻普 |
262352-17-0 |
详细
|
| NVP 231 |
NVP-231 |
362003-83-6 |
详细
|
| Sotuletinib |
BLZ945 |
953769-46-5 |
详细
|
| c-Fms-IN-8 |
|
1255303-58-2 |
详细
|
| Dalcetrapib |
CETP抑制剂 |
211513-37-0 |
详细
|
| c-Fms-IN-1 |
|
885703-64-0 |
详细
|
| Anacetrapib |
安塞曲匹 |
875446-37-0 |
详细
|
| c-Fms-IN-3 |
4-氰基-N-[4-(4-甲基-1-哌嗪基)-2-(4-甲基-1-哌啶基)苯基]-1H-吡咯-2-甲酰胺 |
885704-21-2 |
详细
|
| RGB-286638 |
N-[1,4-二氢-3-[4-[[4-(2-甲氧基乙基)-1-哌嗪基]甲基]苯基]-4-氧代茚并[1,2-C]吡唑-5-基]-N'-4-吗啉基脲盐酸盐 |
784210-87-3 |
详细
|
| Narazaciclib |
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
详细
|
| Indirubin-3′-oxime |
(2Z,3E)-3-(羟基亚氨基)-[2,3'-联吲哚啉亚基]-2'-酮 |
667463-82-3 |
详细
|
| GLPG2451 |
|
2055015-61-5 |
详细
|
| Evacetrapib (LY2484595) |
反式-4-[[(5S)-5-[[[3,5-双(三氟甲基)苯基]甲基](2-甲基-2H-四氮唑-5-基)氨基]-2,3,4,5-四氢-7,9-二甲基-1H-1-苯并氮杂卓-1-基]甲基]环己烷羧酸 |
1186486-62-3 |
详细
|
| Olacaftor |
|
1897384-89-2 |
详细
|
| Bamocaftor |
2204245-48-5 |
2204245-48-5 |
详细
|
| Icenticaftor |
3-氨基-6-甲氧基-N-[(2S)-3,3,3-三氟-2-羟基-2-甲基丙基]-5-(三氟甲基)-2-吡啶甲酰胺 |
1334546-77-8 |
详细
|
| Elexacaftor |
|
2216712-66-0 |
详细
|
| HS-243 |
|
848249-10-5 |
详细
|
| Rintodestrant |
|
2088518-51-6 |
详细
|